Avalo Therapeutics Inc. (AVTX:NASDAQ) soared at $0.12, representing a gain of 45.5%. On Tue, Sep 12, 2023, AVTX:NASDAQ touched a New 2-Week High of $0.12. The stock appeared on our News Catalysts scanner on Tue, Sep 12, 2023 at 07:15 AM in the 'AGREEMENT' category. From Tue, Aug 29, 2023, the stock recorded 22.22% Up Days and 10.00% Green Days
The stock spiked on Tue, Sep 12, 2023 at $0.17 with a volume of 279M+.
About Avalo Therapeutics Inc. (AVTX:NASDAQ)
Avalo Therapeutics Inc is a clinical-stage precision medicine company that discovers, develops, and commercializes targeted therapeutics for patients with significant unmet clinical needs in...
Top 10 Gainers:
- IronNet Inc. (IRNT:NYSE), 172.73%
- Republic First Bancorp, Inc. (FRBK:NASDAQ), 133.24%
- WeWork Inc. Class A (WE:NYSE), 86.97%
- Signature Bank (SBNY:NASDAQ), 66.67%
- Axcella Health Inc. (AXLA:NASDAQ), 59.17%
- Vinco Ventures Inc. (BBIG:NASDAQ), 50%
- Avalo Therapeutics Inc. (AVTX:NASDAQ), 45.47%
- Wheels Up Experience Inc. Class A (UP:NYSE), 36.55%
- SRAX, Inc. (SRAX:NASDAQ), 36.36%
- Impel NeuroPharma Inc. (IMPL:NASDAQ), 34.55%